1. Home
  2. GIL vs BMRN Comparison

GIL vs BMRN Comparison

Compare GIL & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gildan Activewear Inc. Sub. Vot.

GIL

Gildan Activewear Inc. Sub. Vot.

HOLD

Current Price

$71.19

Market Cap

11.5B

ML Signal

HOLD

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$63.10

Market Cap

10.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GIL
BMRN
Founded
1946
1996
Country
Canada
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5B
10.0B
IPO Year
1999
1999

Fundamental Metrics

Financial Performance
Metric
GIL
BMRN
Price
$71.19
$63.10
Analyst Decision
Strong Buy
Buy
Analyst Count
8
21
Target Price
$75.25
$90.10
AVG Volume (30 Days)
1.2M
1.9M
Earning Date
01-01-0001
04-22-2026
Dividend Yield
1.27%
N/A
EPS Growth
N/A
154.02
EPS
N/A
2.04
Revenue
N/A
$1,313,646,000.00
Revenue This Year
$7.50
$13.53
Revenue Next Year
$100.40
$10.40
P/E Ratio
$23.11
$31.09
Revenue Growth
N/A
17.62
52 Week Low
$39.28
$50.76
52 Week High
$73.70
$73.51

Technical Indicators

Market Signals
Indicator
GIL
BMRN
Relative Strength Index (RSI) 62.58 72.31
Support Level $71.08 $59.38
Resistance Level $73.70 $63.75
Average True Range (ATR) 1.65 1.93
MACD -0.03 0.55
Stochastic Oscillator 74.14 94.59

Price Performance

Historical Comparison
GIL
BMRN

About GIL Gildan Activewear Inc. Sub. Vot.

Gildan is a vertically integrated designer and manufacturer of basic apparel, including T-shirts, underwear, socks, and hosiery. Its primary market is the sale of blank T-shirts, sweatshirts, and other apparel to wholesalers, major clothing brands, and printers (printwear). Gildan also sells branded clothing through retail and direct-to-consumer channels. Brands include Gildan, American Apparel, Comfort Colors, and Goldtoe. Gildan produces most of its clothing at factories in Latin America but has been ramping up production at its new facility in Bangladesh. Incorporated in 1984, the Montreal-based company operates internationally but generates nearly 90% of its sales in the US. Gildan is acquiring its US rival Hanesbrands to bolster its consumer and printwear operations.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: